| ₹ crore | Q2 FY27 | Q2 FY26 | Change |
|---|---|---|---|
| Revenue | 2,511 | 2,349 | +6.9% |
| EBITDA | 48.2 | 45.3 | +6.5% |
| Profit before tax | 48.2 | 45.3 | +6.5% |
| Net profit | 43.1 | 40.8 | +5.5% |
| EPS | ₹0.45 | ₹0.43 | +4.7% |
| Tap a line for its trend | Q2 FY27Sep 2026 | Q1 FY27Jun 2026 | Q4 FY26Mar 2026 | Q3 FY26Dec 2025 | Q2 FY26Sep 2025 |
|---|
| 2,511 | 4,347 | 1,268 | 4,273 | 2,349 | |
Expenses | |||||
| 2,522 | 4,279 | 1,364 | 4,173 | 2,237 | |
| 48.2 | 31.5 | 38.6 | 30.8 | 45.3 | |
| 48.2 | 31.5 | 38.6 | 30.8 | 45.3 | |
Profit | |||||
| 48.2 | 31.5 | 38.6 | 30.8 | 45.3 | |
| 43.1 | 28.1 | 34.7 | 27.7 | 40.8 | |
Per share | |||||
| ₹0.45 | ₹0.30 | ₹0.37 | ₹0.29 | ₹0.43 | |
Revenue detail — as filed | |||||
| 35.1 | 34.6 | 29.3 | 30.8 | 28.1 | |
| −33.4 | 2,269 | −1,716 | 1,304 | 60.1 | |
Expense detail — as filed | |||||
| 228 | 215 | 234 | 179 | 175 | |
| 165 | 117 | 196 | 183 | 148 | |
| 165 | 117 | 196 | 183 | 148 | |
| −1.2 | 0.0 | 0.0 | 0.0 | 0.0 | |
| −2.9 | 0.5 | −0.2 | 0.7 | 0.0 | |
Profit build-up — alternate / pre-Ind-AS tags | |||||
| 48.2 | 31.5 | 38.6 | 30.8 | 45.3 | |
| 5.2 | 3.4 | 3.9 | 3.2 | 4.5 | |
| 5.2 | 3.4 | 3.9 | 3.2 | 4.5 | |
| 43.1 | 28.1 | 34.7 | 27.7 | 40.8 | |
| 43.1 | 28.1 | 34.7 | 27.7 | 40.8 | |
| 564 | 559 | 530 | 496 | 468 | |
Per share — as-filed variants | |||||
| ₹0.45 | ₹0.30 | ₹0.37 | ₹0.29 | ₹0.43 | |
| ₹0.45 | ₹0.30 | ₹0.37 | ₹0.29 | ₹0.43 | |
Appropriations & transfers | |||||
| 689 | 684 | 655 | 621 | 593 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
Insurance — revenue account (Policyholders') | |||||
| 2,581 | 2,161 | 3,114 | 2,889 | 2,295 | |
| 2,553 | 2,048 | 3,061 | 2,867 | 2,260 | |
| 642 | 466 | 674 | 938 | 575 | |
| 1,641 | 1,117 | 2,127 | 1,668 | 1,420 | |
| 298 | 578 | 314 | 283 | 300 | |
| 99.6 | 75.3 | 123 | 127 | 86.4 | |
| 40.0 | 24.1 | 51.2 | 34.8 | 42.9 | |
| 25.5 | 17.8 | 22.4 | 20.9 | 19.1 | |
| 526 | 447 | 580 | 527 | 427 | |
| 361 | 330 | 384 | 345 | 278 | |
| 7.6 | 7.2 | 3.7 | 2.8 | 1.7 | |
| 1,199 | 835 | 1,256 | 988 | 1,261 | |
| 798 | 2,997 | −472 | 2,658 | 530 | |
| 0.0 | 0.0 | 118 | 0.0 | 0.0 | |
| 6.2 | 5.1 | 7.5 | 6.4 | 8.6 | |
| 0.0 | 0.0 | −0.2 | 0.0 | 19.4 | |
| −11.5 | 67.8 | −96.9 | 99.9 | 112 | |
| −11.5 | 67.8 | −96.9 | 99.9 | 112 | |
| −15.4 | 40.5 | −26.1 | 1.1 | 69.1 | |
| 29.8 | 29.5 | 28.0 | 29.1 | 27.9 | |
Insurance — Shareholders' account | |||||
| 33.9 | 35.9 | 29.3 | 30.8 | 28.1 | |
| 37.8 | 63.2 | −41.5 | 129 | 71.3 | |
| −10.4 | 31.7 | −80.1 | 98.7 | 26.0 | |
| 3.9 | 27.3 | −70.8 | 98.7 | 43.2 | |
| −15.1 | 24.1 | −83.6 | 95.2 | 24.4 | |
| 3.9 | 27.3 | −70.8 | 98.7 | 43.2 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
Insurance — result & transfers | |||||
| −5.3 | 72.9 | 28.9 | 106 | 121 | |
| 6.4 | 6.6 | 6.3 | 5.9 | 5.1 | |
| −1.3 | 1.3 | 0.0 | 0.0 | 0.0 | |
| −15.1 | 24.1 | −83.6 | 95.2 | 24.4 | |
Insurance — fund NPAs | |||||
| 83.3 | 86.1 | 86.1 | 86.1 | 86.1 | |
| ₹0.04 | ₹0.04 | ₹0.04 | ₹0.05 | ₹0.06 | |
| 31.2 | 32.4 | 32.4 | 32.4 | 32.4 | |
| ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | |
| −0.0 | 0.0 | −0.0 | 0.0 | −0.0 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
Insurance — IRDAI ratios (as filed, not percentages) | |||||
| 1.80× | 1.98× | 1.90× | 1.91× | 1.98× | |
| ₹1.80 | ₹1.98 | ₹1.90 | ₹1.91 | ₹1.98 | |
| ₹0.82 | ₹0.85 | ₹0.85 | ₹0.88 | ₹0.86 | |
| ₹0.20 | ₹0.21 | ₹0.19 | ₹0.18 | ₹0.19 | |
| ₹0.81 | ₹0.82 | ₹0.82 | ₹0.85 | ₹0.82 | |
| ₹0.72 | ₹0.72 | ₹0.70 | ₹0.67 | ₹0.71 | |
| ₹0.66 | ₹0.70 | ₹0.63 | ₹0.63 | ₹0.63 | |
| ₹0.60 | ₹0.61 | ₹0.59 | ₹0.61 | ₹0.61 | |
| ₹0.52 | ₹0.53 | ₹0.51 | ₹0.57 | ₹0.59 | |
Regulatory disclosures — filed alongside, not part of the P&L | |||||
| 1,097 | — | 922 | — | 1,057 | |
From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.
In ₹ Crore except Per Share 3 Months Ending | Q2 FY26 30/09/2025 | Q3 FY26 31/12/2025 | Q4 FY26 31/03/2026 | Q1 FY27 30/06/2026 | Q2 FY27 30/09/2026 | |
|---|---|---|---|---|---|---|
| Total Income | 2,349.3 | 4,272.5 | 1,267.5 | 4,347.0 | 2,511.0 | |
| Expenses | ||||||
| Total Expenses | 2,237.0 | 4,172.7 | 1,364.5 | 4,279.2 | 2,522.5 | |
| EBITDA | 45.3 | 30.8 | 38.6 | 31.5 | 48.2 | |
| EBIT | 45.3 | 30.8 | 38.6 | 31.5 | 48.2 | |
| Profit | ||||||
| Pretax Income | 45.3 | 30.8 | 38.6 | 31.5 | 48.2 | |
| Net Income | 40.8 | 27.7 | 34.7 | 28.1 | 43.1 | |
| Per Share | ||||||
| Basic EPS | 0.43 | 0.29 | 0.37 | 0.30 | 0.45 | |
| Revenue Detail — as filed | ||||||
| + Investment Income | 28.1 | 30.8 | 29.3 | 34.6 | 35.1 | |
| + Income from Investments (net) | 60.1 | 1,304.3 | -1,715.9 | 2,268.8 | -33.4 | |
| Expense Detail — as filed | ||||||
| + Employee Remuneration & Welfare | 174.8 | 179.4 | 234.3 | 215.0 | 228.2 | |
| + Commission | 148.5 | 182.7 | 196.1 | 117.2 | 165.1 | |
| + Commission (net) | 148.5 | 182.7 | 196.1 | 117.2 | 165.1 | |
| + Provision — Diminution in Investments | 0.0 | 0.0 | 0.0 | 0.0 | -1.2 | |
| + Provision — Doubtful Debts incl. Write-off | 0.0 | 0.7 | -0.2 | 0.5 | -2.9 | |
| Profit Build-up — Alternate / Pre-Ind-AS Tags | ||||||
| Profit / (Loss) before Tax | 45.3 | 30.8 | 38.6 | 31.5 | 48.2 | |
| + Current Taxes | 4.5 | 3.2 | 3.9 | 3.4 | 5.2 | |
| + Provisions for Taxes | 4.5 | 3.2 | 3.9 | 3.4 | 5.2 | |
| PAT before Extraordinary Items | 40.8 | 27.7 | 34.7 | 28.1 | 43.1 | |
| PAT after Extraordinary Items | 40.8 | 27.7 | 34.7 | 28.1 | 43.1 | |
| Profit Carried to Balance Sheet | 468.1 | 495.7 | 530.5 | 558.6 | 563.7 | |
| Per Share — as-filed variants | ||||||
| Basic & Diluted EPS before Extraordinary (not annualised) | 0.43 | 0.29 | 0.37 | 0.30 | 0.45 | |
| Basic & Diluted EPS after Extraordinary (not annualised) | 0.43 | 0.29 | 0.37 | 0.30 | 0.45 | |
| Appropriations & Transfers | ||||||
| Reserves & Surplus excl. Revaluation Reserve | 593.1 | 620.7 | 655.5 | 683.6 | 688.7 | |
| + Final Dividend | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Insurance — Revenue Account (Policyholders') | ||||||
| + Gross Premium Income | 2,294.9 | 2,889.3 | 3,114.2 | 2,161.1 | 2,581.3 | |
| + Net Premium Income | 2,259.7 | 2,867.2 | 3,060.7 | 2,047.5 | 2,553.2 | |
| + First-year Premium | 575.1 | 938.0 | 673.9 | 466.1 | 641.9 | |
| + Renewal Premium | 1,419.8 | 1,668.4 | 2,126.8 | 1,117.4 | 1,640.9 | |
| + Single Premium | 300.0 | 282.9 | 313.6 | 577.6 | 298.4 | |
| + Commission — First-year Premium | 86.4 | 127.0 | 122.6 | 75.3 | 99.6 | |
| + Commission — Renewal Premium | 42.9 | 34.8 | 51.2 | 24.1 | 40.0 | |
| + Commission — Single Premium | 19.1 | 20.9 | 22.4 | 17.8 | 25.5 | |
| + Expenses of Management | 427.0 | 527.4 | 580.3 | 447.2 | 526.0 | |
| + Operating Expenses — Insurance Business | 278.5 | 344.7 | 384.2 | 330.0 | 361.0 | |
| + Expenses — Non-insurance | 1.7 | 2.8 | 3.7 | 7.2 | 7.6 | |
| + Benefits Paid (net) | 1,260.5 | 987.6 | 1,256.0 | 834.7 | 1,199.4 | |
| + Change in Actuarial Liability | 530.2 | 2,657.6 | -471.7 | 2,997.3 | 798.2 | |
| + Bonus Allocated to Policyholders | 0.0 | 0.0 | 118.3 | 0.0 | 0.0 | |
| + Interim Bonus Paid | 8.6 | 6.4 | 7.5 | 5.1 | 6.2 | |
| + GST on Linked Charges | 19.4 | 0.0 | -0.2 | 0.0 | 0.0 | |
| Surplus in the Revenue Account | 112.3 | 99.9 | -96.9 | 67.8 | -11.5 | |
| Net Surplus / (Deficit) | 112.3 | 99.9 | -96.9 | 67.8 | -11.5 | |
| + Funds for Future Appropriation | 69.1 | 1.1 | -26.1 | 40.5 | -15.4 | |
| + Policyholders' Liabilities to Shareholders' Fund | 27.9 | 29.1 | 28.0 | 29.5 | 29.8 | |
| Insurance — Shareholders' Account | ||||||
| + Income under Shareholders' Account | 28.1 | 30.8 | 29.3 | 35.9 | 33.9 | |
| + Shareholders' Account Income | 71.3 | 129.5 | -41.5 | 63.2 | 37.8 | |
| + Shareholders' Account Expenses | 26.0 | 98.7 | -80.1 | 31.7 | -10.4 | |
| + Transfer from Policyholders' Account | 43.2 | 98.7 | -70.8 | 27.3 | 3.9 | |
| + Transfer of Funds to Policyholders' Account | 24.4 | 95.2 | -83.6 | 24.1 | -15.1 | |
| + Transferred to Shareholders' Account | 43.2 | 98.7 | -70.8 | 27.3 | 3.9 | |
| Shareholders' Fund — with Unrealised Gains | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Shareholders' Fund — without Unrealised Gains | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Insurance — Result & Transfers | ||||||
| Surplus / (Deficit) | 120.9 | 106.3 | 28.9 | 72.9 | -5.3 | |
| + Other Income — Policyholders' Account | 5.1 | 5.9 | 6.3 | 6.6 | 6.4 | |
| + Other Income — Shareholders' Account | 0.0 | 0.0 | 0.0 | 1.3 | -1.3 | |
| + Transfer of Funds from Shareholders' Account | 24.4 | 95.2 | -83.6 | 24.1 | -15.1 | |
| Insurance — Fund NPAs | ||||||
| + Gross NPAs — Shareholders' Fund | 86.1 | 86.1 | 86.1 | 86.1 | 83.3 | |
| + Gross NPA % — Shareholders' Fund | 0.06 | 0.05 | 0.04 | 0.04 | 0.04 | |
| + Gross NPAs — Linked Non-participating | 32.4 | 32.4 | 32.4 | 32.4 | 31.2 | |
| + Gross NPA % — Linked Non-participating | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| + Linked Non-participating — with Unrealised Gains | -0.0 | 0.0 | -0.0 | 0.0 | -0.0 | |
| + Linked Non-participating — without Unrealised Gains | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| + Non-linked Participating — with Unrealised Gains | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| + Non-linked Participating — without Unrealised Gains | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| + Non-linked Non-participating — with Unrealised Gains | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| + Non-linked Non-participating — without Unrealised Gains | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Insurance — IRDAI Ratios (as filed, not percentages) | ||||||
| Solvency Ratio (x, one scale) | 1.98 | 1.91 | 1.90 | 1.98 | 1.80 | |
| Solvency Ratio (as filed) | 1.98 | 1.91 | 1.90 | 1.98 | 1.80 | |
| Conservation Ratio | 0.86 | 0.88 | 0.85 | 0.85 | 0.82 | |
| Expenses of Management Ratio | 0.19 | 0.18 | 0.19 | 0.21 | 0.20 | |
| Persistency — 13th Month | 0.82 | 0.85 | 0.82 | 0.82 | 0.81 | |
| Persistency — 25th Month | 0.71 | 0.67 | 0.70 | 0.72 | 0.72 | |
| Persistency — 37th Month | 0.63 | 0.63 | 0.63 | 0.70 | 0.66 | |
| Persistency — 49th Month | 0.61 | 0.61 | 0.59 | 0.61 | 0.60 | |
| Persistency — 61st Month | 0.59 | 0.57 | 0.51 | 0.53 | 0.52 | |
| Regulatory Disclosures — filed alongside, not part of the P&L | ||||||
| Related-party Transactions — During the Period | 1,057.1 | — | 922.3 | — | 1,096.6 | |
| Other Filed Concepts — mapped but not yet placed in the schedule | ||||||
| Other Operating Expenses | 103.7 | 165.3 | 149.9 | 115.0 | 132.7 | |
Filed with NSE on Friday, 9 October 2026 at 4:37 pm IST
Canara HSBC Life Insurance (NSE: CANHLIFE) reported its Q2 FY27 results (July–September 2026) on Friday, 9 October 2026 at 4:37 pm IST. Consolidated net profit was ₹43.1 crore, up 5.5% from ₹40.8 crore in Q2 FY26 and up 53.0% from ₹28.1 crore in Q1 FY27.
Consolidated net profit was ₹43.1 crore, up 5.5% from ₹40.8 crore in Q2 FY26 and up 53.0% from ₹28.1 crore in Q1 FY27.
Net profit by quarter: ₹27.7 crore in Q3 FY26, ₹34.7 crore in Q4 FY26, ₹28.1 crore in Q1 FY27 and ₹43.1 crore in Q2 FY27. That is ₹134 crore over the four quarters.
On Friday, 9 October 2026 at 4:37 pm IST, in its results filing to the stock exchanges. A year earlier it reported Q2 FY26 on 27 October 2025.
Against Q2 FY26, net profit was up 5.5% at ₹43.1 crore. Against Q1 FY27, net profit was up 53.0%.
Basic earnings per share were ₹0.45, against ₹0.43 in Q2 FY26.
Consolidated net profit was ₹127 crore in FY26 (April 2025–March 2026).
Q3 FY27 covers October–December 2026. Listed companies must publish quarterly results within 45 days of the quarter's end (SEBI listing rules, Regulation 33), so the results are due by 14 February 2027. The company tells the exchanges the date of the board meeting at least two working days before it.
From Canara HSBC Life Insurance's own consolidated results filings to NSE, in ₹ crore as filed (Q2 FY27 on 9 October 2026). Growth compares the same consolidated figures a year and a quarter earlier.
Consolidated figures from the company's filings to NSE. Every company's results dates this season are in the Q2 FY27 results calendar, part of Alpha Plus.